Trials / Completed
CompletedNCT04344080
Effect of CytoSorb Adsorber on Hemodynamic and Immunological Parameters in Critical Ill Patients With COVID-19
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Universitätsklinikum Hamburg-Eppendorf · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
This prospective randomized single Center study investigates to what extent the physical elimination of the inflammatory mediators using the CytoSorb adsorber reduces the morbidity of severely and critically ill patients with Covid-19.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | CytoSorb-Therapy | Additional use of Cytosorb-Adsorber in patients with COVID-19 and need for extracorporeal circulation (continuous renal replacement therapy or extracorporeal membrane oxygenation) |
Timeline
- Start date
- 2020-04-01
- Primary completion
- 2021-04-10
- Completion
- 2021-04-28
- First posted
- 2020-04-14
- Last updated
- 2022-09-21
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT04344080. Inclusion in this directory is not an endorsement.